NG2 expression in MLL rearranged acute myeloid leukaemia is restricted to monoblastic cases
- 24 December 1999
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 107 (3) , 674-676
- https://doi.org/10.1046/j.1365-2141.1999.01730.x
Abstract
Expression of NG2 has been reported in the majority of paediatric acute leukaemia (AL) cases with MLL rearrangement. We demonstrated 7.1 positivity in 2/3 paediatric and 4/11 adult MLL rearranged acute myeloid leukaemia (AML) but in 0/28 adult AML without MLL rearrangement, thus extending the 100% specificity to adult cases. Positivity correlated with stage of maturation arrest since it was found in 0/6 immature AML but in 6/8 monoblastic cases. These data demonstrate that, if NG2 expression in AL is the (in)direct result of MLL rearrangement, such activation is restricted to a monoblastic population in AML. They also have practical implications for NG2 diagnostic screening strategies.Keywords
This publication has 11 references indexed in Scilit:
- Ten novel 11q23 chromosomal partner sitesLeukemia, 1998
- MLL Gene Rearrangement, Cytogenetic 11q23 Abnormalities, and Expression of the NG2 Molecule in Infant Acute Myeloid LeukemiaBlood, 1997
- Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting ageBlood, 1996
- Incidence and characterization of MLL gene (11q23) rearrangements in acute myeloid leukemia M1 and M5Blood, 1996
- Human homologue of the rat chondroitin sulfate proteoglycan, NG2, detected by monoclonal antibody 7.1, identifies childhood acute lymphoblastic leukemias with t(4;11)(q21;q23) or t(11;19)(q23;p13) and MLL gene rearrangementsBlood, 1996
- The human homologue of rat NG2, a chondroitin sulfate proteoglycan, is not expressed on the cell surface of normal hematopoietic cells but is expressed by acute myeloid leukemia blasts from poor-prognosis patients with abnormalities of chromosome band 11q23Blood, 1996
- Abnormalities of Chromosome Band 11q23 and the MLL Gene in Pediatric Myelomonocytic and Monoblastic LeukemiasJournal of Pediatric Hematology/Oncology, 1995